2SHAH M A, SCHWARTZ G K. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy[J]. Clin Cancer Res, 2001,7: 2168-2181.
3SHAIN K H, DALTON W S. Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR[J]. Mol Cancer Ther, 2001,1: 69- 78.
4Gulubova M V. Expression of cell adhesion molecules, their ligands and tumour necrosis factor alpha in the liver of patients with metastatic gastrointestinal carcinomas [J]. Histochem J, 2002, 34 ( 1/2 ) : 66 - 77.
5Hirahashi J, Takayanagi A, Hishikawa K, et al. Overexpression of truncated I kappa B alpha potentiates TNF-alpha-induced apoptosis in mesangial cells[J]. Kidney lnt, 2000, 57(3) : 959 -968.
6Green S K, Francia G, Isidoro C, et al. Antiadhesive antibodies targeting E-cadherin sensitize muhicellular tumor spheroids to chemotherapy in vitro[J]. Mol Cancer Ther, 2004, 3(2) : 149 - 159.
7Dimitrove D I, Yang X, Reichenbach N L, et al. Lentivirus-mediated transduction of PKR into CD34 ( + ) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny[ J]. J Interferon Cytokine Res, 2005, 25(6): 345-360.
8Gomez C E, Vandermeeren A M, Garcia M A, et al. Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a Vaccinia virus recombinant[J]. Virul J, 2005, 2: 81.
9Donze O, Deng J, Curran J, et al. The protein kinase PKR : a molecular clock that sequentially activates survival and death programs[J]. EMBO J, 2004, 23(3) : 564 -571.
10Wang B D, Kline C L, Pastor D M, et al. Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5- FU through mediation of an NF kappaB and microRNA network[ J]. Mol Cancer, 2010, 9( 1 ) : 98.
